P35.14 NGS-Based Molecular Profiling of ‘Quadruple-Negative’ (EGFR/KRAS/ALK/ROS1) Advanced Non-Small-Cell Lung Cancer (aNSCLC).
Abstract
Potential clinical benefit deriving from upfront multi-gene profiling versus standard-of-care molecular analysis in advanced non-small-cell lung cancer (aNSCLC) is still debated. In a multicenter national program of FoundationOne CDx (FM1) access, we analyzed the results of NGS-based extended multigene molecular profiling in a cohort of patients selected for being ‘quadruple (EGFR/KRAS/ALK/ROS1) - negative’...
Paper Details
Title
P35.14 NGS-Based Molecular Profiling of ‘Quadruple-Negative’ (EGFR/KRAS/ALK/ROS1) Advanced Non-Small-Cell Lung Cancer (aNSCLC).
Published Date
Mar 1, 2021
Journal
Volume
16
Issue
3
Pages
S425 - S426
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History